REILEY PHARMACEUTICALS
Reiley Pharmaceuticals is a developer of biopharmaceutical products designed to treat pain, cancer and infectious diseases. The company's biopharmaceutical products, enabling patients to recover pain, cancer and infectious diseases.
REILEY PHARMACEUTICALS
Industry:
Biotechnology Pharmaceutical
Founded:
2014-01-01
Address:
San Francisco, California, United States
Country:
United States
Total Employee:
1+
Status:
Active
Contact:
408-718-9027
Total Funding:
3.28 M USD
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Employees Featured
More informations about "Reiley Pharmaceuticals"
Reiley Pharmaceuticals - Crunchbase Company Profile & Funding
Reiley Pharmaceuticals is a developer of biopharmaceutical products designed to treat pain, cancer, and infectious diseases.See details»
Reiley Pharmaceuticals Company Profile 2024: …
Developer of biopharmaceutical products intended to cater to people in San Francisco, California. The company's diagnostic radiopharmaceutical and therapeutic products are designed to treat pain, cancer, and infectious …See details»
Reiley Pharmaceuticals - Funding, Financials, Valuation & Investors
Reiley Pharmaceuticals is a developer of biopharmaceutical products designed to treat pain, cancer, and infectious diseases.See details»
REILEY PHARMACEUTICALS INC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for REILEY PHARMACEUTICALS INC of San Francisco, CA. Get the latest business insights from Dun & …See details»
Organization | Reiley Pharmaceuticals Inc.
Reiley Pharmaceuticals Inc. Report issue For profit Phase 1 Founded: San Jose CA United States (2014)See details»
Reiley Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Reiley Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, Drug:Technetium-99m-RPI-T-087.See details»
Reiley Pharmaceuticals Stock Data, Filings, Earnings, News
Get the latest news, data and filings for Reiley Pharmaceuticals, with free alerts. Includes transcripts, social sentiment, and more.See details»
Reiley Pharmaceuticals - Crunchbase
Reiley Pharmaceuticals is a developer of biopharmaceutical products designed to treat pain, cancer, and infectious diseases.See details»
Reiley Pharmaceuticals - Company, United States - SWFI
Reiley Pharmaceuticals is a Company located in United States, North America, and was founded in 2014.See details»
Market and State of LBP Diagnosis Mark Reiley, Founder’s …
Reiley Pharmaceutical Inc. (RPI) is a precision medical company developing diagnostic imaging drugs. These imaging agents include a selective COX-2 inhibitor combined with a Technetium …See details»
Reiley Pharmaceuticals - Products, Competitors, Financials, …
Reiley Pharmaceuticals is a pharmaceutical company. The company was founded in 2014 and is based in San Francisco, California. You're one click away from the most comprehensive, …See details»
Reiley Pharmaceuticals - Updates, News, Events, Signals & Triggers
Reiley Pharmaceuticals is a developer of biopharmaceutical products designed to treat pain, cancer, and infectious diseases.See details»
Reiley Pharmaceuticals, Inc. - fund raising filing
Reiley Pharmaceuticals, Inc. - Most recent fund raising on June 5, 2024 raised $97,655 in Equity.See details»
Reiley Pharmaceuticals Stock Price, Funding, Valuation, Revenue ...
Jun 4, 2024 · See Reiley Pharmaceuticals funding rounds, investors, investments, exits and more. Evaluate their financials based on Reiley Pharmaceuticals's post-money valuation and revenue.See details»
Reiley Pharmaceuticals - CB Insights
Explore {Reiley Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Patents Assigned to Reiley Pharmaceuticals, Inc.
Dec 18, 2015 · Justia Patents Patents Assigned to Reiley Pharmaceuticals, Inc. Abstract: The present disclosure provides platinum-containing conjugates that selectively target and kill …See details»
Reiley Pharmaceuticals - Contacts, Employees, Board Members, …
Reiley Pharmaceuticals is a developer of biopharmaceutical products designed to treat pain, cancer, and infectious diseases.See details»
COX-2-targeting, platinum-containing conjugates and their use in …
Patent US10053478B2 - COX-2-targeting, platinum-containing conjugates and their use in the treatment of tumors and cancers (US 10,053,478 B2); Owner: Reiley Pharmaceuticals, Inc.; …See details»
Mark Reiley - Reiley Pharmaceuticals Inc - LinkedIn
· Experience: Reiley Pharmaceuticals Inc · Education: George Washington University School of Medicine · Location: Washington · 500+ connections on LinkedIn. View Mark Reiley’s profile on...See details»
Reiley Pharmaceuticals - Tech Stack, Apps, Patents & Trademarks
Reiley Pharmaceuticals is a developer of biopharmaceutical products designed to treat pain, cancer, and infectious diseases.See details»